166 related articles for article (PubMed ID: 35140839)
1. Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia.
Liu W; Wu Z; Yu Y; Qiao C; Zhu H; Hong M; Zhu Y; Qian S; Chen S; Wu D; Li J; Jin H
Oxid Med Cell Longev; 2022; 2022():5885342. PubMed ID: 35140839
[TBL] [Abstract][Full Text] [Related]
2. microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.
Su R; Dong L; Zou D; Zhao H; Ren Y; Li F; Yi P; Li L; Zhu Y; Ma Y; Wang J; Wang F; Yu J
Oncogene; 2016 Nov; 35(46):6001-6014. PubMed ID: 27086927
[TBL] [Abstract][Full Text] [Related]
3. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
[TBL] [Abstract][Full Text] [Related]
4. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
5. VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice.
Gentner E; Vegi NM; Mulaw MA; Mandal T; Bamezai S; Claus R; Tasdogan A; Quintanilla-Martinez L; Grunenberg A; Döhner K; Döhner H; Bullinger L; Haferlach T; Buske C; Rawat VP; Feuring-Buske M
Oncotarget; 2016 Dec; 7(52):86889-86901. PubMed ID: 27888632
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.
Liao Z; Li J; Wu J; Liu J; Sun S
Curr Mol Med; 2021; 21(10):819-831. PubMed ID: 33475071
[TBL] [Abstract][Full Text] [Related]
7. Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.
Leonards K; Almosailleakh M; Tauchmann S; Bagger FO; Thirant C; Juge S; Bock T; Méreau H; Bezerra MF; Tzankov A; Ivanek R; Losson R; Peters AHFM; Mercher T; Schwaller J
Nat Commun; 2020 Jun; 11(1):2807. PubMed ID: 32533074
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Long Noncoding RNA Plasmacytoma Variant Translocation 1 with Antisense Locked Nucleic Acid GapmeRs Exerts Tumor-Suppressive Functions in Human Acute Erythroleukemia Cells Through Downregulation of
Salehi M; Sharifi M; Bagheri M
Cancer Biother Radiopharm; 2019 Aug; 34(6):371-379. PubMed ID: 30141968
[No Abstract] [Full Text] [Related]
9. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
[TBL] [Abstract][Full Text] [Related]
10. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
Di Genua C; Nerlov C
Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869
[TBL] [Abstract][Full Text] [Related]
11. [Expression of circ-KEL in acute myeloid leukemia and its regulatory mechanisms in leukemic cells].
Wu ZJ; Sun Q; Gu DL; Wang LQ; Li JY; Jin H
Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):230-237. PubMed ID: 33910309
[No Abstract] [Full Text] [Related]
12. Acute erythroid leukemia.
Zuo Z; Polski JM; Kasyan A; Medeiros LJ
Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
[TBL] [Abstract][Full Text] [Related]
13. Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1.
Lam LT; Ronchini C; Norton J; Capobianco AJ; Bresnick EH
J Biol Chem; 2000 Jun; 275(26):19676-84. PubMed ID: 10783395
[TBL] [Abstract][Full Text] [Related]
14. LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia.
Tatsumi G; Kawahara M; Yamamoto R; Hishizawa M; Kito K; Suzuki T; Takaori-Kondo A; Andoh A
Leukemia; 2020 Mar; 34(3):746-758. PubMed ID: 31676828
[TBL] [Abstract][Full Text] [Related]
15. The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.
Ge Y; LaFiura KM; Dombkowski AA; Chen Q; Payton SG; Buck SA; Salagrama S; Diakiw AE; Matherly LH; Taub JW
Leukemia; 2008 Mar; 22(3):521-9. PubMed ID: 18094719
[TBL] [Abstract][Full Text] [Related]
16. Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells.
Long W; Liu S; Li XX; Shen X; Zeng J; Luo JS; Li KR; Wu AG; Yu L; Qin DL; Hu GQ; Yang J; Wu JM
Pharmacol Res; 2021 Apr; 166():105491. PubMed ID: 33582247
[TBL] [Abstract][Full Text] [Related]
17. Erythroleukemia-historical perspectives and recent advances in diagnosis and management.
Boddu P; Benton CB; Wang W; Borthakur G; Khoury JD; Pemmaraju N
Blood Rev; 2018 Mar; 32(2):96-105. PubMed ID: 28965757
[TBL] [Abstract][Full Text] [Related]
18. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
[TBL] [Abstract][Full Text] [Related]
19. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
Lee WY; Weinberg OK; Pinkus GS
Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
[TBL] [Abstract][Full Text] [Related]
20. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
